Literature DB >> 11311312

Development of the pulmonary surfactant system in the green sea turtle, Chelonia mydas.

S D Johnston1, C B Daniels, D T Booth.   

Abstract

This study describes the developmental changes in pulmonary surfactant (PS) lipids throughout incubation in the sea turtle, Chelonia mydas. Total phospholipid (PL), disaturated phospholipid (DSP) and cholesterol (Chol) harvested from lung washings increased with advancing incubation, where secretion was maximal at pipping, coincident with the onset of pulmonary ventilation. The DSP/PL ratio increased, whereas the Chol/PL and the Chol/DSP ratio declined throughout development. The phospholipids, therefore, are independently regulated from Chol and their development matches that of mammals. To explore whether hypoxia could elicit an effect on the development of the PS system, embryos were exposed to a chronic dose of 17% O2 for the final approximately 40% of incubation. Hypoxia did not affect incubation time, absolute, nor relative abundance of the surfactant lipids, demonstrating that the development of the system is robust and that embryonic development continues unabated under mild hypoxia. Hypoxia-incubated hatchlings had lighter wet lung weights than those from normoxia, inferring that mild hypoxia facilitates lung clearance in this species.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311312     DOI: 10.1016/s0034-5687(00)00225-5

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  2 in total

1.  Effects of biotic and abiotic factors on the oxygen content of green sea turtle nests during embryogenesis.

Authors:  Chiu-Lin Chen; Chun-Chun Wang; I-Jiunn Cheng
Journal:  J Comp Physiol B       Date:  2010-05-18       Impact factor: 2.200

2.  Lipid profiling suggests species specificity and minimal seasonal variation in Pacific Green and Hawksbill Turtle plasma.

Authors:  Chelsea E Clyde-Brockway; Christina R Ferreira; Elizabeth A Flaherty; Frank V Paladino
Journal:  PLoS One       Date:  2021-07-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.